Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Hydroxyprogesterone Caproate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 305Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pharmexcil announces strategic pharma cooperation between India and Taiwan
    Pharmexcil announces strategic pharma cooperation between India and Taiwan

    03 Jun 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=169522&sid=1

    PHARMABIZ
    03 Jun 2024
    Share Share
    US FDA withdraws approval for Covis Pharma's preterm birth prevention drug
    US FDA withdraws approval for Covis Pharma's preterm birth prevention drug

    07 Apr 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-withdraws-approval-covis-pharmas-preterm-birth-prevention-drug-2023-04-06/

    REUTERS
    07 Apr 2023
    Share Share
    Controversial drug for preterm birth to be withdrawn, maker says
    Controversial drug for preterm birth to be withdrawn, maker says

    09 Mar 2023

    // BIOPHARMADIVE

    https://www.biopharmadive.com/news/fda-makena-withdrawal-preterm-birth-drug-covis/644418/

    BIOPHARMADIVE
    09 Mar 2023
    Share Share
    Covis granted FDA hearing over premature-birth med Makena
    Covis granted FDA hearing over premature-birth med Makena

    21 Aug 2021

    // N. H. Dunn FIERCEPHARMA

    https://www.fiercepharma.com/pharma/covis-granted-fda-hearing-latest-twist-over-controversial-premature-birth-med-makena

    N. H. Dunn FIERCEPHARMA
    21 Aug 2021
    Share Share
    FDA, unmoved by new meta-analysis, still recommends Makena withdrawal
    FDA, unmoved by new meta-analysis, still recommends Makena withdrawal

    30 Mar 2021

    // Kari Oakes RAPS

    https://www.raps.org/news-and-articles/news-articles/2021/3/fda-unmoved-by-new-meta-analysis-still-recommends

    Kari Oakes RAPS
    30 Mar 2021
    Share Share
    AMAG Pharmaceuticals Requests Hearing to Maintain Makena®
    AMAG Pharmaceuticals Requests Hearing to Maintain Makena®

    14 Oct 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/10/14/2108720/0/en/AMAG-Pharmaceuticals-Requests-Hearing-to-Maintain-Makena-Hydroxyprogesterone-Caproate-Injection-as-a-Treatment-Option-for-Clinically-Indicated-Pregnant-Patients.html

    GLOBENEWSWIRE
    14 Oct 2020
    Share Share